Table 4.

Relationship between thyroid hormone levels and DKD in women.

Characteristics	Groups	n	Model1 OR (95%CI)	P value	Model2 OR (95%CI)	P value
TSH	<2.5	125	Reference		Reference
	≥2.50	101	1.369(0.781–2.402)	0.273	1.251(0.627–2.495)	0.524
FT3	Q1(<4.15)	54	Reference		Reference
	Q2(4.15 ≤ Q2<4.48)	58	0.518(0.238–1.130)	0.098	0.506(0.191–1.341)	0.171
	Q3(4.48 ≤ Q3<4.80)	56	0.500(0.227–1.102)	0.086	0.483(0.182–1.283)	0.144
	Q4(≥4.80)	58	0.436(0.197–0.967)	0.041	0.413(0.152–1.119)	0.082
FT4	Q1(<14.56)	56	Reference		Reference
	Q2(14.56 ≤ Q2<16.06)	57	1.056(0.481–2.316)	0.893	0.912(0.319–2.608)	0.864
	Q3(16.06 ≤ Q3<17.54)	57	0.824(0.368–1.843)	0.637	0.582(0.204–1.664)	0.313
	Q4(≥17.54)	56	1.084(0.493–2.383)	0.841	1.781(0.657–4.828)	0.256
TPO	<78	193	Reference		Reference
	≥78	33	0.919(0.412–2.048)	0.836	1.120(0.408–3.079)	0.825

Model1: unadjusted;

Model2: adjusted for age, duration of T2DM, BMI, smoking, Hypertension, ARB/ACEI medication, insulin medication, metformin medication, HbA1c, TG, TC.